As the trade agenda returns to the headlines, it is important to remember that there is both good news and bad news in the world of U.S. trade. And the shorthand for the division between the two is the difference between policy and politics.

President Obama indicated his seriousness about exports when he committed to double them by 2015, but he has given conflicting signals about his commitment to trade liberalization. While the administration has praised the passage of the FTAs with Panama, Colombia, and South Korea, the president waited far too long to submit the legislation to Congress.

The president's trip to meet with leaders and revive the Trans-Pacific Partnership (TPP) closely resembles a trip he took two years ago. We've been down this road before. Past experience cautions against reading too much into Obama's embrace of the TPP.

There is a distinction between perception and text that affects policymaking, as evidenced by recent congressional action on international trade.

President Obama and his team successfully concluded negotiations on the U.S.-South Korea free trade agreement (KORUS). Here are eight questions and answers on what just happened.

Legislation to expose today's biologics to easier competition, after legitimate patents have expired, is going to accelerate development of improved products.

There remains an enormous amount of room for businesses to continue enjoying explosive levels of growth, but only if they can gain access to new markets.

U.S. Trade Representative Susan C. Schwab and others on the Doha round, the WTO, and the future of free trade.